ACS Revascularization Strategy Selector Tool

Clinical calculation support · Verify results before clinical use

Clinical assessment

Select the current clinical findings. This tool supports triage discussion and does not replace bedside assessment.

Decision support

Use the working diagnosis after ECG and initial clinical assessment.

Select Yes if present. This is an emergency feature.

Select Yes for acute decompensation suggesting very-high-risk ACS and requiring urgent assessment.

Select Yes for persistent/recurrent ischemia despite appropriate treatment.

Select Yes when a serious electrical instability is present.

Select Yes for any relevant high-risk finding, such as confirmed NSTEMI, dynamic ST/T changes, transient ST elevation, or GRACE score >140. Heart failure may indicate high or very high risk depending on severity.

This flags the need to individualize procedural and antithrombotic planning; it does not independently determine the timing of angiography.

Clinical context

Revascularization decisions in acute coronary syndrome depend on the ECG-based diagnosis, hemodynamic and electrical stability, ongoing ischemia, ischemic risk, coronary anatomy, comorbidities, and patient-specific considerations.

How to interpret the pathway

  • STEMI: activate an immediate reperfusion pathway. Primary PCI is preferred when achievable within the recommended time; if not, assess fibrinolysis eligibility and the required transfer strategy.
  • NSTE-ACS with very-high-risk features: urgent assessment for immediate invasive management is required. Examples include hemodynamic instability/cardiogenic shock, acute heart failure related to ongoing ischemia, refractory or recurrent ischemia, and life-threatening arrhythmia.
  • NSTE-ACS with high-risk features: an invasive strategy during hospitalization is generally recommended; angiography within 24 hours should be considered when indicated by the risk profile.
  • Stable, lower-risk presentations: consider selective invasive assessment after appropriate diagnostic and risk stratification. This tool does not calculate a GRACE score or independently classify a patient as low risk.

Important limitations

The selector simplifies a complex clinical decision and does not assess symptom duration, ECG tracings, serial biomarkers, GRACE score, coronary anatomy, contraindications to fibrinolysis, or suitability for PCI versus CABG. Use the full guideline and local STEMI/NSTE-ACS pathway.

References

Rao SV, O'Donoghue ML, Ruel M, et al.

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation/J Am Coll Cardiol. 2025.

Official AHA guideline page
Byrne RA, Rossello X, Coughlan JJ, et al.

2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023;44(38):3720–3826.

https://doi.org/10.1093/eurheartj/ehad191
Clinical disclaimer: This tool provides general decision support and must not delay emergency assessment, reperfusion, or invasive management when clinically indicated. Final decisions should be made by the treating clinical team using the patient's full presentation, current guidelines, contraindications, patient preferences, and local protocols.